IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 10

Issue Published : 114

Article Submitted : 18802

Article Published : 7888

Total Authors : 20844

Total Reviewer : 759

Total Countries : 142

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Immunosuppressants
Authors Name: D.Rama Brahma Reddy , K. Malleswari , Mudamanchu Renuka
Download E-Certificate: Download
Author Reg. ID:
IJRTI_189155
Published Paper Id: IJRTI2402018
Published In: Volume 9 Issue 2, February-2024
DOI:
Abstract: Immunosuppressant is a class of medicine that inhibit or decrease the intensity of the immune response in the body. Most of these medications are used to allow the body less likely to resist a transplanted organ .In solid organ transplanted organ. In solid organ transplantation immunosuppressive agents are needed for the activation of early -stage immunosuppression ,the management of organ rejection .The emergence of novel agent and improvement in immune suppression regimens after transplantation are significant factor leading to this progress .However, these drugs also increase the risk of infection , cancers and specific adverse side effects specific to each agent in patients particularly in pregnant women and fertility issues. Corona virus disease being hot topic of debate is has given positive outcome to immunosuppressive drug how ever need more attention I future. Transplant centres across the utilize multiple immunosuppression protocol’s nevertheless , each patient can require an individually formulated immunosuppression regimen to manage the advantages and possible damage of treatment thus eliminating the likelihood of the primary disease recurrence.
Keywords: Immunosuppression, immunosuppressants, Calcineurin Inhibitors.
Cite Article: "Immunosuppressants", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.9, Issue 2, page no.103 - 107, February-2024, Available :http://www.ijrti.org/papers/IJRTI2402018.pdf
Downloads: 000205130
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2402018
Registration ID:189155
Published In: Volume 9 Issue 2, February-2024
DOI (Digital Object Identifier):
Page No: 103 - 107
Country: -, -, India
Research Area: Other
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2402018
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2402018
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner